Hologic (HOLX) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Hologic (HOLX) PT Raised to $48 at Needham & Company
August 1, 2018 7:55 AM EDTNeedham & Company raised its price target on Hologic (NASDAQ: HOLX) to $48.00 (from $43.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "HOLX's F3Q18 revenue and EPS beat consensus. Management raised its FY18 revenue guidance and narrowed its EPS guidance range.... More
Hologic (HOLX) PT Raised to $45 at Cowen
August 1, 2018 7:26 AM EDTCowen raised its price target on Hologic (NASDAQ: HOLX) to $45.00 (from $44.00) while maintaining an Outperform rating.
Analyst Doug Schenkel commented, "Hologic beat FQ3 revenue and EPS expectations even adjusted for favorable non-core items. While there are numerous moving parts, updated full year... More
Hologic (HOLX) PT Raised to $46 at Evercore ISI
August 1, 2018 7:17 AM EDTEvercore ISI raised its price target on Hologic (NASDAQ: HOLX) to $46.00 (from $43.00) while maintaining a Outperform rating.
What analyst Vijay Kumar liked in the quarter:
Overall organic revenue beat was driven by outperformanceFull year guidance organic growth was raised by... More